Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 flexible extended regimen DSG/EE 150/20 for primary and secondary dysmenorrhea
jRCT2031230276Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary dysmenorrhea (PD) and dysmenorrhea comparing DSG/EE 150/20 with Placebo (2 arms). Started Jul 2023; status: completed.
02
Drugs
ethinyl estradiol + desogestrel
03
Conditions
primary dysmenorrhea (PD)dysmenorrhea
Beyond the preview
Go deeper on jRCT2031230276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230276.